These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9079237)

  • 1. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs.
    Hirota T; Nakamura A; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):175-81. PubMed ID: 9079237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A; Hirota T; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 2nd communication: tissue levels and enzyme activity in rats after repeated administration, and placental and milk transfer after single administration.
    Nakamura A; Hirota T; Sugihara K; Watanabe S; Tougou K; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):160-8. PubMed ID: 9079235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
    Nakamura A; Sugihara K; Hirota T; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the anticholinergic drug with calcium antagonistic activity, (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate, on lower urinary tract function in decerebrated dogs.
    Kimura Y; Fukui H; Hamada K; Ogasawara T; Yamazaki C; Ukai Y; Yoshikuni Y; Kimura K
    Arzneimittelforschung; 1997 Feb; 47(2):182-9. PubMed ID: 9079238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the anticholinergic drug with calcium antagonistic activity, (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate, on lower urinary tract function in rhesus monkeys.
    Kimura Y; Hamada K; Fukui H; Ogasawara T; Ukai Y; Yoshikuni Y; Kimura K
    Arzneimittelforschung; 1997 Feb; 47(2):189-94. PubMed ID: 9079239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
    Nonaka K; Tsujioka T; Tougou K; Mukai H
    Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxicokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in mice and rats during 13-week dietary administration].
    Nakazawa M; Kitayama E; Adachi T; Yoshida M; Ishibashi S; Yoshikawa K; Kajihara T; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():177-85. PubMed ID: 9170607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
    Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
    Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral single-dose and 13-week repeat-dose toxicity studies of RCC-36, the active metabolite of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in rats].
    Furukawa S; Kouyama H; Kikumori M; Taniguchi Y; Nishimori T; Ishibashi S; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():93-124. PubMed ID: 9170604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 3rd communication: metabolism in rats, rabbits, dogs and monkeys, and effects on hepatic drug-metabolizing enzyme activities in rats after repeated administration.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 Jul; 49(7):612-7. PubMed ID: 10442210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of NS-105, a novel cognition enhancer. 2nd communication: distribution and transfer into fetus and milk after single administration, and effects of repeated administration on pharmacokinetics and hepatic drug-metabolizing enzyme activities in rats.
    Mukai H; Sugimoto T; Ago M; Morino A; Takaichi M; Ogawa Y; Seki H; Matsuura C; Esumi Y
    Arzneimittelforschung; 1999 Dec; 49(12):977-85. PubMed ID: 10635441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of efonidipine hydrochloride metabolites in rats.
    Nakabeppu H; Nakajima A; Kamikawaji Y; Shinozaki Y
    Arzneimittelforschung; 1995 Jul; 45(7):766-70. PubMed ID: 8573219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A 26-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 9-week recovery test].
    Okasaki K; Baba S; Ikeda H; Chihaya Y; Satake S; Nagata R; Ishibashi S; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():59-92. PubMed ID: 9170603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
    Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Single-dose toxicity studies of (+/-)-4-diethylamino-1, 1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate(NS-21), a novel drug for urinary frequency and incontinence, in mice, rats and dogs].
    Nishiguchi Y; Yoshida M; Tarui M; Nakazawa M; Oka T; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():1-13. PubMed ID: 9170600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A 12-month oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in dogs followed by a 2-month recovery test].
    Yoshida M; Kawaminami A; Tawaratani T; Ishibashi S; Nakazawa M; Kitayama E; Oka T; Adachi T; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():147-75. PubMed ID: 9170606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and metabolism of a RAS farnesyl transferase inhibitor in rats and dogs: in vitro-in vivo correlation.
    Singh R; Chen IW; Jin L; Silva MV; Arison BH; Lin JH; Wong BK
    Drug Metab Dispos; 2001 Dec; 29(12):1578-87. PubMed ID: 11717177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of a new dihydropyridine calcium antagonist in rats and dogs.
    Takayama F; Iwasawa Y; Saito K; Shiratori K; Ohtawa M
    Xenobiotica; 1989 Dec; 19(12):1407-20. PubMed ID: 2618091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.